English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
11 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Audio of 911 call released
Gold rises to new heights
SpaceX launches Crew-10
Consumer sentiment drops
Permanently shuts route
ISIS leader killed in Iraq
Kupp signs with Seahawks
Court lifts Trump's DEI block
Felony gun possession arrest
Laceration hazard recall
Pleads not guilty
‘Ted Lasso’ is coming back
Influential WY senator dies
Senate confirmation hearing
Top intelligence agency visit
Man hit by motorcade, dies
Legendary sportswriter dies
Coffee creamer recall
Strikes deal with DOGE
Influencer leaves Australia
March megastorm
Child abuse images sentence
Wins longest-ever Iditarod
Hamas to release hostage
Plane engine catches fire
反馈